Literature DB >> 9826388

Chlamydia trachomatis IncA is localized to the inclusion membrane and is recognized by antisera from infected humans and primates.

J P Bannantine1, W E Stamm, R J Suchland, D D Rockey.   

Abstract

Chlamydia psittaci produces a collection of proteins, termed IncA, IncB, and IncC, that are localized to the chlamydial inclusion membrane. In this report we demonstrate that IncA is also produced by Chlamydia trachomatis. C. trachomatis IncA is structurally similar to C. psittaci IncA and is also localized to the inclusion membrane. Immunoblot analysis demonstrated that sera from C. trachomatis-infected patients and from experimentally infected monkeys both recognized C. trachomatis IncA.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9826388      PMCID: PMC108764     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

Review 1.  The cell biology of infection by intracellular bacterial pathogens.

Authors:  J A Theriot
Journal:  Annu Rev Cell Dev Biol       Date:  1995       Impact factor: 13.827

2.  The late chlamydial inclusion membrane is not derived from the endocytic pathway and is relatively deficient in host proteins.

Authors:  T Taraska; D M Ward; R S Ajioka; P B Wyrick; S R Davis-Kaplan; C H Davis; J Kaplan
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

3.  Vesicular interactions of the Chlamydia trachomatis inclusion are determined by chlamydial early protein synthesis rather than route of entry.

Authors:  M A Scidmore; D D Rockey; E R Fischer; R A Heinzen; T Hackstadt
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

4.  The Chlamydia trachomatis parasitophorous vacuolar membrane is not passively permeable to low-molecular-weight compounds.

Authors:  R A Heinzen; T Hackstadt
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

Review 5.  Protein sorting by transport vesicles.

Authors:  J E Rothman; F T Wieland
Journal:  Science       Date:  1996-04-12       Impact factor: 47.728

6.  Differential interaction with endocytic and exocytic pathways distinguish parasitophorous vacuoles of Coxiella burnetii and Chlamydia trachomatis.

Authors:  R A Heinzen; M A Scidmore; D D Rockey; T Hackstadt
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

7.  Lipid metabolism in Chlamydia trachomatis-infected cells: directed trafficking of Golgi-derived sphingolipids to the chlamydial inclusion.

Authors:  T Hackstadt; M A Scidmore; D D Rockey
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

8.  Protein antigens of Chlamydia psittaci present in infected cells but not detected in the infectious elementary body.

Authors:  D D Rockey; J L Rosquist
Journal:  Infect Immun       Date:  1994-01       Impact factor: 3.441

9.  Chlamydia trachomatis interrupts an exocytic pathway to acquire endogenously synthesized sphingomyelin in transit from the Golgi apparatus to the plasma membrane.

Authors:  T Hackstadt; D D Rockey; R A Heinzen; M A Scidmore
Journal:  EMBO J       Date:  1996-03-01       Impact factor: 11.598

10.  Sphingolipids and glycoproteins are differentially trafficked to the Chlamydia trachomatis inclusion.

Authors:  M A Scidmore; E R Fischer; T Hackstadt
Journal:  J Cell Biol       Date:  1996-07       Impact factor: 10.539

View more
  50 in total

1.  Normal IncA expression and fusogenicity of inclusions in Chlamydia trachomatis isolates with the incA I47T mutation.

Authors:  Y Pannekoek; A van der Ende; P P Eijk; J van Marle; M A de Witte; J M Ossewaarde; A J van den Brule; S A Morré; J Dankert
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

Review 2.  Genome sequencing and our understanding of chlamydiae.

Authors:  D D Rockey; J Lenart; R S Stephens
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

3.  cPLA2 regulates the expression of type I interferons and intracellular immunity to Chlamydia trachomatis.

Authors:  Mark J Vignola; David F Kashatus; Gregory A Taylor; Christopher M Counter; Raphael H Valdivia
Journal:  J Biol Chem       Date:  2010-05-07       Impact factor: 5.157

4.  Tyrosine phosphorylation of the Helicobacter pylori CagA antigen after cag-driven host cell translocation.

Authors:  M Stein; R Rappuoli; A Covacci
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

5.  Chlamydial antigens colocalize within IncA-laden fibers extending from the inclusion membrane into the host cytosol.

Authors:  W J Brown; Y A W Skeiky; P Probst; D D Rockey
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

6.  Expression and localization of type III secretion-related proteins of Chlamydia pneumoniae.

Authors:  R Lugert; M Kuhns; T Polch; U Gross
Journal:  Med Microbiol Immunol       Date:  2003-10-31       Impact factor: 3.402

7.  A meta-analysis of affinity purification-mass spectrometry experimental systems used to identify eukaryotic and chlamydial proteins at the Chlamydia trachomatis inclusion membrane.

Authors:  Macy G Olson; Scot P Ouellette; Elizabeth A Rucks
Journal:  J Proteomics       Date:  2019-11-21       Impact factor: 4.044

8.  The Chlamydophila abortus genome sequence reveals an array of variable proteins that contribute to interspecies variation.

Authors:  Nicholas R Thomson; Corin Yeats; Kenneth Bell; Matthew T G Holden; Stephen D Bentley; Morag Livingstone; Ana M Cerdeño-Tárraga; Barbara Harris; Jon Doggett; Doug Ormond; Karen Mungall; Kay Clarke; Theresa Feltwell; Zahra Hance; Mandy Sanders; Michael A Quail; Claire Price; Bart G Barrell; Julian Parkhill; David Longbottom
Journal:  Genome Res       Date:  2005-04-18       Impact factor: 9.043

9.  Development of secondary inclusions in cells infected by Chlamydia trachomatis.

Authors:  Robert J Suchland; Daniel D Rockey; Sara K Weeks; Damir T Alzhanov; Walter E Stamm
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

10.  Identification of concomitant infection with Chlamydia trachomatis IncA-negative mutant and wild-type strains by genomic, transcriptional, and biological characterizations.

Authors:  Robert J Suchland; Brendan M Jeffrey; Minsheng Xia; Ajay Bhatia; Hencelyn G Chu; Daniel D Rockey; Walter E Stamm
Journal:  Infect Immun       Date:  2008-10-13       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.